Daclatasvir and Sofosbuvir Therapy Enhance Monocyte Phenotypic Changes in Naive Chronic Hepatitis C Patients: A Prospective Cohort Study

Table 1

The baseline clinical and laboratory data of study populations.

	CHC patient
Age (years) Mean ±SD	52.2±13.8
Male/female	60/40
HCV RNA viral load (IU/ml)
Mean ±SD, log10 IU/ml	6.09±0.55
Median (range) log10 IU/ml	6.09 (5.18-6.91)
≥ 800,000 IU/ml	58%
< 800,000 IU/ml	42%